Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.

Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.

BACKGROUND: Annualized relapse rates (ARR) in the placebo cohorts of phase-3 randomized controlled trials (RCT) of new treatments for relapsing remitting multiple sclerosis (RRMS) have decreased substantially during the last two decades. The causes of these changes are not clear. We consider a bette...

Full description

Bibliographic Details
Main Authors: Jan-Patrick Stellmann, Anneke Neuhaus, Lena Herich, Sven Schippling, Matthias Roeckel, Martin Daumer, Roland Martin, Christoph Heesen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3510222?pdf=render

Internet

http://europepmc.org/articles/PMC3510222?pdf=render

Similar Items